Hepatitis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hepatitis stocks.

Recent Signals

Date Stock Signal Type
2021-05-13 AEMD Lower Bollinger Band Walk Weakness
2021-05-13 AEMD Expansion Breakdown Bearish Swing Setup
2021-05-13 ALGS Doji - Bullish? Reversal
2021-05-13 EIGR NR7 Range Contraction
2021-05-13 ETNB Expansion Breakdown Bearish Swing Setup
2021-05-13 ETNB Expansion Pivot Sell Setup Bearish Swing Setup
2021-05-13 GNFT Bollinger Band Squeeze Range Contraction
2021-05-13 GNFT MACD Bearish Signal Line Cross Bearish
2021-05-13 GNFT Stochastic Reached Oversold Weakness
2021-05-13 MTCR New 52 Week Low Weakness
2021-05-13 MTCR New 52 Week Closing Low Bearish
2021-05-13 MTCR Stochastic Reached Oversold Weakness
2021-05-13 PLRX MACD Bearish Signal Line Cross Bearish
2021-05-13 PLRX 20 DMA Resistance Bearish

Recent News for Hepatitis Stocks

Date Stock Title
May 13 MTCR Metacrine reports Q1 results
May 13 TERN Terns Pharmaceuticals EPS misses by $0.35
May 13 TERN Terns Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 13 MTCR Metacrine Accelerates MET409 Clinical Development Milestone and Reports First-Quarter 2021 Results
May 13 AKRO Akero Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
May 13 PLRX Analysts Are Upgrading Pliant Therapeutics, Inc. (NASDAQ:PLRX) After Its Latest Results
May 12 ETNB 89bio EPS misses by $0.04
May 12 GNFT GENFIT: Reports First Quarter 2021 Financial Information
May 12 ETNB 89bio Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 12 IVA Inventiva reports first quarter 2021 financial information and updates on the collaboration with AbbVie in auto-immune diseases
May 12 IVA Earnings Scheduled For May 12, 2021
May 11 GNFT GENFIT Provides Pipeline Update and Launch of New Clinical Programs
May 11 MGLN Mightier Video Game Pilot Program with Magellan Healthcare Leads to 45% Improvement in Symptoms for Children with Autism
May 11 MTCR Metacrine to Present at 2021 RBC Global Healthcare Conference
May 10 PLRX Pliant Therapeutics EPS misses by $0.01, misses on revenue
May 10 ALGS Aligos Therapeutics EPS beats by $0.16
May 10 PLRX Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
May 10 GNFT GENFIT Annual Combined General Meeting of June 15, 2021 - Availability of Preparatory Documents
May 10 ALGS Aligos Therapeutics Reports Recent Business Progress and First Quarter 2021 Financial Results
May 10 EIGR Eiger BioPharmaceuticals'(NASDAQ:EIGR) Share Price Is Down 56% Over The Past Five Years.

Hepatitis is inflammation of the liver tissue. Some people have no symptoms whereas others develop yellow discoloration of the skin and whites of the eyes, poor appetite, vomiting, tiredness, abdominal pain, or diarrhea. Hepatitis may be temporary (acute) or long term (chronic) depending on whether it lasts for less than or more than six months. Acute hepatitis can sometimes resolve on its own, progress to chronic hepatitis, or rarely result in acute liver failure. Over time the chronic form may progress to scarring of the liver, liver failure, or liver cancer.The most common cause of hepatitis worldwide is viruses. Other causes include heavy alcohol use, certain medications, toxins, other infections, autoimmune diseases, and non-alcoholic steatohepatitis (NASH). There are five main types of viral hepatitis: type A, B, C, D, and E. Hepatitis A and E are mainly spread by contaminated food and water. Hepatitis B is mainly sexually transmitted, but may also be passed from mother to baby during pregnancy or childbirth. Both hepatitis B and C are commonly spread through infected blood such as may occur during needle sharing by intravenous drug users. Hepatitis D can only infect people already infected with hepatitis B.Hepatitis A, B, and D are preventable with immunization. Medications may be used to treat chronic cases of viral hepatitis. There is no specific treatment for NASH; however, a healthy lifestyle, including physical activity, a healthy diet, and weight loss, is important. Autoimmune hepatitis may be treated with medications to suppress the immune system. A liver transplant may also be an option in certain cases.Worldwide in 2015, hepatitis A occurred in about 114 million people, chronic hepatitis B affected about 343 million people and chronic hepatitis C about 142 million people. In the United States, NASH affects about 11 million people and alcoholic hepatitis affects about 5 million people. Hepatitis results in more than a million deaths a year, most of which occur indirectly from liver scarring or liver cancer. In the United States, hepatitis A is estimated to occur in about 2,500 people a year and results in about 75 deaths. The word is derived from the Greek hêpar (ἧπαρ), meaning "liver", and -itis (-ῖτις), meaning "inflammation".

More about Hepatitis
Browse All Tags